ノースカロライナにおける膵臓がんの臨床試験
ノースカロライナ内の拠点で、膵臓がんに関する34件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06995898Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- FirstHealth of the Carolinas, Pinehurst
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07562152Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Duke Cancer Center, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07621718DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- University of North Carolina Hospitals at Hillsborough, Hillsborough
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Duke Cancer Center, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US035, Chapel Hill
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Duke University Medical Center, Durham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0100, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680Promoting CT Engagement for Pancreatic Cancer With App
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中
18歳以上 · 全性別 · 2026/09/16更新 · NCT06252545Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
- East Carolina University, Greenville
- 他1件
被験者募集中観察研究
50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- University of North Carolina, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07644559Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill
- University of North Carolina, Chapel Hill
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05245500Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
- Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中第1相
18歳〜99歳 · 全性別 · 2026/08/19更新 · NCT03454035A Study of DM002 in Patients With Advanced Solid Tumors
- Carolina BioOncology Institute, LLC, Huntersville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06751329Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
- Levine Cancer Institute, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/23更新 · NCT05376592Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Duke University Medical Center, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06937177Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Duke Cancer Institute /ID# 276267, Durham
- Carolina BioOncology Institute /ID# 232597, Huntersville
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT05005403A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/10更新 · NCT06835569Autologous CAR-T Cells Targeting B7-H3 in PDAC
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06158139Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Duke Cancer Center, Durham
- Carolina BioOncology Institute, Huntersville
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- Southeastern Medical Oncology Center-Jacksonville, Jacksonville
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/23更新 · NCT06483555Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Carolina BioOncology Institute, Huntersville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Charlotte
- Ohio State University-Telemedicine, Raleigh
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中第2相
18歳〜99歳 · 全性別 · 2026/01/13更新 · NCT03977233SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Levine Cancer Institute, Charlotte
被験者募集中第1相
18歳以上 · 全性別 · 2025/08/15更新 · NCT04429542APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of North Carolina, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2025/06/27更新 · NCT03175224Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
被験者募集中第2相
18歳以上 · 全性別 · 2025/03/25更新 · NCT05776524ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。